NDRG1 and triple-negative breast carcinoma: Molecular studies examining triple-negative breast cancer cells have demonstrated that NDRG1 expression can promote the ubiquitination and degradation of receptor tyrosine kinase, HER3, via the interaction with the ubiquitin ligases, neural precursor cell expressed developmentally downregulated protein (NEDD4) (204).